APA (7th ed.) Citation

JJ, A., LL, B., J, C., M, K., T, D., HA, B., . . . SS, S. (2025). An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo. Protein science : a publication of the Protein Society, 34(10), e70292. https://doi.org/10.1002/pro.70292

Chicago Style (17th ed.) Citation

JJ, Adams, et al. "An Asymmetric Tetrabody Is a Potent and Efficacious Agonist of the Erythropoietin Receptor in Vitro and in Vivo." Protein Science : A Publication of the Protein Society 34, no. 10 (2025): e70292. https://doi.org/10.1002/pro.70292.

MLA (9th ed.) Citation

JJ, Adams, et al. "An Asymmetric Tetrabody Is a Potent and Efficacious Agonist of the Erythropoietin Receptor in Vitro and in Vivo." Protein Science : A Publication of the Protein Society, vol. 34, no. 10, 2025, p. e70292, https://doi.org/10.1002/pro.70292.